|
Delayed
Nasdaq
13:33:08 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 108.36 USD | +1.36% |
|
-6.15% | +35.82% |
Main features
| US74347R2141 | Fees | 1.19% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (EUR) | 89.74M | Replication Method | Indirect (Synthetic) |
| Number of securities | - | AuM evolution | - | Date of creation | 2010-04-06 |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIB | Delayed | |
CBOE
| BIB | Real-time |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Biotechnology, Pharmaceuticals |
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | US$108.36 | +1.36% | 2,600 |
| 26-10-06 | US$106.90 | -4.60% | 13,568 |
| 26-10-05 | US$112.06 | +2.05% | 9,836 |
| 26-10-02 | US$109.80 | -0.61% | 10,030 |
| 26-10-01 | US$110.47 | -4.32% | 5,078 |
- Stock Market
- ETF
- BIB ETF
Select your edition
All financial news and data tailored to specific country editions
